{"id":75132,"date":"2020-10-01T16:10:00","date_gmt":"2020-10-01T16:10:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2736934"},"modified":"2020-10-01T16:10:00","modified_gmt":"2020-10-01T16:10:00","slug":"global-tissue-diagnostics-market-is-set-for-robust-growth-to-reach-around-usd-6-30-billion-by-2025","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2020\/10\/01\/global-tissue-diagnostics-market-is-set-for-robust-growth-to-reach-around-usd-6-30-billion-by-2025\/","title":{"rendered":"Global Tissue Diagnostics Market Is Set For Robust Growth, To Reach Around USD 6.30 Billion by 2025"},"content":{"rendered":"

Zion Market Research has published a new report titled “Tissue Diagnostics Market by Product (Consumables and Instruments); by Technology (Special Staining, Digital Pathology and Workflow Management, In situ Hybridization, and Immunohistochemistry); by Disease (Non-small Cell Lung Cancer, Prostate Cancer, Lymphoma, Gastric Cancer, Breast Cancer and Other Diseases); by End User (Contract Research Organizations, Research Laboratories, Pharmaceutical Companies, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2025”. According to the report, global demand for tissue diagnostics market<\/a> was valued at approximately USD 3.86 billion in 2018, and is expected to generate revenue of around USD 6.30 billion by end of 2025, growing at a CAGR of around 7.3% between 2019 and 2025.<\/p>\n

\"Global<\/p>\n

Tissue diagnostics is considered as a gold standard for cancer diagnosis. Tissue diagnostics is a valuable diagnostic tool for diagnosis of a large number of pathological conditions. Using a surgical procedure, tissue is excised from patient and is sent for evaluation by histologic, molecular and ultrastructural examination to pathology laboratory.<\/p>\n

Request For Free Sample Report @https:\/\/www.zionmarketresearch.com\/sample\/tissue-diagnostics-market<\/a><\/strong><\/p>\n

Growing prevalence of all types of cancer across the globe, technological advancements, favorable reimbursement policies, increasing health awareness, increasing healthcare expenditure, rising aging population and government initiatives to create awareness are factors that drive the demand for tissue diagnostics market. However, high capital investment and R&D expenses, high degree of consolidation may impede the market growth. Growing demand for personalized medicine is expected to bring new growth opportunities for tissue diagnostics market.<\/p>\n

Tissue diagnostics market is segmented based on disease, technology, end user product, and region. Based on product, tissue diagnostics market is categorized into instruments and consumables. Consumables segment is sub categorized into probes, kits, antibodies and reagents. Instruments segment is sub categorized into tissue-processing systems, slide-staining systems, scanners and other instruments. The consumables segment held dominating revenue share in 2018. This large share is attributable to consistent and frequent use of consumables. Technological advancements in instrumentation will boost the demand for advanced instruments over the forecast period.<\/p>\n

Based on technology market is segmented into in situ hybridization, digital pathology and workflow management, immunohistochemistry and special staining. Availability of variety of products based on immunohistochemistry and growing demand for in vitro diagnostics are factors that attribute to the largest market share of immunohistochemistry technology segment.<\/p>\n

The disease segment is divided into prostate cancer, lymphoma, non-small cell lung cancer, breast cancer, gastric cancer, and other diseases. In 2018, breast cancer segment held largest market share. Worldwide, second most prevalent type of cancer is breast cancer. Growing prevalence and increasing health awareness are factors attributing to the largest market share of this segment.<\/p>\n

Based on end user, tissue diagnostics market is segmented into research laboratories, contract research organizations, hospitals, pharmaceutical companies, and others. Research laboratories will register highest CAGR in the coming years. Hospitals dominated the market in 2018 as result of large patient pool, better accessibility and availability of developed infrastructure.<\/p>\n

At region level, North America held largest revenue share in 2018 for tissue diagnostics market. Growing cancer prevalence, favorable reimbursement policies, availability of developed R&D infrastructure and technological advancements are factors promoting market growth in this region. Europe was second largest regional market. Increasing research based on tissue diagnosis, availability of developed infrastructure, rise in R&D spending, increasing cancer burden are some of factors that boost market growth in this region. Latin America is expected to witness moderate growth over the forecast period. Asia Pacific region is projected to register highest growth over the forecast period. Growing cancer prevalence, rise in aging population, increasing disposable income and healthcare spending, government focus on infrastructure improvement and increasing health awareness are factors promoting tissue diagnostics market growth in Asia Pacific. Lack of infrastructure, funds and health awareness may lead to sluggish growth in Middle East and Africa.<\/p>\n

Major players included in the report are Roche, Abbott, Danaher, Merck, Thermo Fisher Scientific, Sakura Finetek Japan, Agilent Technologies, Abcam, BD, QIAGEN, A. Menarini Diagnostics, Sienna Cancer Diagnostics, Royal Philips, and Cell Signaling Technology among others.<\/p>\n

The report segment of global tissue diagnostics market as follows:<\/strong><\/p>\n

Global Tissue Diagnostics<\/strong>Market<\/strong>: By<\/strong>Product<\/strong><\/p>\n